BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 31, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2020
View Archived Issues
Data reported from ENCODE phase III
Read More
New phase I trial investigates JNJ-66525433 for ulcerative colitis
Read More
Roche and Genentech descirbe RIPK1 inhibitors
Read More
New STING agonists synthesized at Nankai University
Read More
Dana-Farber Cancer Institute patents DOT1L degraders
Read More
Vertex Pharmaceuticals discovers sodium channel protein type 10 subunit alpha blockers
Read More
GTPase KRAS G12C inhibitors identified described by Mirati Therapeutics and Array BioPharma
Read More
Src SH3 domain: an antithrombotic target without compromising homeostasis
Read More
European Commission approves Piqray for HR+/HER- breast cancer with PIK3CA mutation
Read More
FDA clears IND for phase I study of recombinant IAP SYN-020
Read More
J&J initiates first-in-human study with Ad26.COV2.S vaccine candidate against SARS-COV-2
Read More
Phase Ib data with Xeris' XP-0863 support progression to phase III for epilepsy
Read More
[18F]SMBT-1 shows promise for imaging astrogliosis in Alzheimer's disease
Read More
Phase III EMPEROR-Reduced trial of empagliflozin in HFrEF meets primary endpoint
Read More
Terns reports phase I data on TERN-201 for NASH
Read More
Cynata reports 2-year data from phase I study of CYP-001 in acute GvHD
Read More
Lexicon focuses on LX-9211, sells Xermelo
Read More
CDH12 identified as biomarker of kidney injury in patients with posterior urethral valves
Read More
Trillium advances dose escalation in phase Ib trial of TTI-621 in CTCL
Read More
FDA approves Tecentriq with Cotellic and Zelboraf for BRAF V600 mutation-positive advanced melanoma
Read More
Organoid-based drug screening unveils the role of menin-HIF axis in endometrial cancers
Read More
Clinical evaluation of [18F]EKZ-001 PET radiotracer to quantify HDAC6 brain expression
Read More
